Zerodol TH 4 mg Tablet

Zerodol TH 4 mg Tablet is a pain-relieving medicine with Aceclofenac (100mg) and Thiocolchicoside (4mg) as an active ingredient. This is a non-steroidal anti-inflammatory drug (NSAID). It is used in the treatment of pain due to muscle spasms. This medicine improves the movement of muscles and provides relief from pain & discomfort linked with muscle spasms. It should be taken in dose and duration as advice by the doctor. Don't take more than the recommended dose.

• Treatment of inflammatory conditions associated with muscle spasm
• Treatment of Pain due to muscle spasm

Every medicine has some side effects that typically manage on their own as your body gets used to the medicine, but some people may experience severe side effects rarely. In that case, the patient should contact the doctor immediately.
Some common side effects of Zerodol TH 4 mg Tablet include:

• Dizziness
• Diarrhea
• Increased liver enzymes
• Nausea
• Dyspepsia
• Abdominal pain

• Take Zerodol TH 4 mg Tablet as prescribed by your doctor. Swallow it as a whole with water and don't chew, crush, or break it.
• This tablet should be taken with or after food. Take it at the same time every day for effective results. Don't miss a dose or overdose the medicine.
  

• Zerodol TH 4 mg Tablet is a pain-relieving medicine with Aceclofenac (100mg) and Thiocolchicoside (4mg) as an active ingredient. This is a non-steroidal anti-inflammatory drug (NSAID).
• Aceclofenac acts by inhibiting the secretion of a few chemical messengers that are responsible for pain and inflammation (redness and swelling).
• Thiocolchicoside is known as a muscle relaxant that works on the centers in the brain & spinal cord to provide relieve from muscle stiffness or spasm and to improve pain as well as movement of muscles.
  

• Samanthula, G., Shrigod, V. V., & Patel, P. N. (2014). Validated stability-indicating assay method for simultaneous determination of aceclofenac and thiocolchicoside using RP-HPLC. Drug research, 64(08), 429-435. https://pubmed.ncbi.nlm.nih.gov/24310363/
• Oikonomou, I., & Akinosoglou, K. (2025, March). Efficacy and safety of the combination of diclofenac and thiocolchicoside in the treatment of low back pain and other conditions: Systematic review of the literature. In Healthcare (Vol. 13, No. 6, p. 677). MDPI. https://pubmed.ncbi.nlm.nih.gov/40150527/
• Nellika, A. M., Mothalampet, A., & Rajagopal, S. (2018). A prospective study comparing the safety and efficacy of combination of aceclofenac and thiocolchicoside against aceclofenac alone in low back pain. https://www.ijbcp.com/index.php/ijbcp/article/view/2176
• Maladkar, M. N., Tekchandani, C. M., & Yadav, A. S. (2019). Targeting the therapeutic need in musculoskeletal inflammatory pain with thiocolchicoside and aceclofenac sustained-release combination therapy. Indian Journal of Pain, 33(2), 71-76. https://www.researchgate.net/publication/335020828_Targeting_the_therapeutic_need_in_musculoskeletal_inflammatory_pain_with_thiocolchicoside_and_aceclofenac_sustained-release_combination_therapy
• Kumar, S., Rani, S., Siwach, R., & Verma, P. (2014). To compare the efficacy and safety of fixed dose combination of thiocolchicoside and aceclofenac versus chlorzoxazone, aceclofenac and paracetamol in patients with acute lower backache associated with muscle spasm. International Journal of Applied and Basic Medical Research, 4(2), 101-105. https://pubmed.ncbi.nlm.nih.gov/25143885/